← Back to guidelines
Anesthesiology6 papers

Juvenile idiopathic arthritis of foot

Last edited: 4/15/2026

Overview

Juvenile idiopathic arthritis (JIA) affecting the foot involves chronic joint inflammation in children, leading to pain, swelling, and functional impairment primarily localized to the foot structures 1.

Diagnosis

  • Clinical evaluation focusing on joint swelling, tenderness, and restricted range of motion in the foot 1.
  • Radiographic imaging to assess for joint space narrowing, erosions, and other structural changes 1.
  • Laboratory tests including ESR, CRP, and RF/anti-CCP antibodies to rule out other conditions and assess disease activity 1.
  • Management

  • First-line treatments: Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation management 1.
  • Disease-modifying antirheumatic drugs (DMARDs): Methotrexate as a cornerstone therapy for moderate to severe cases 1.
  • Biologic agents: TNF inhibitors (e.g., etanercept) for refractory cases or when conventional DMARDs fail 1.
  • Physical therapy: Regular sessions to maintain joint mobility and strength 1.
  • Orthotics: Custom foot orthotics to support joint alignment and reduce stress 1.
  • Pain management: Multimodal approaches including physical modalities and psychological support 1.
  • Special Populations

  • Pediatrics: Tailored treatment plans focusing on minimizing systemic side effects and preserving growth 1.
  • Comorbidities: Close monitoring and integrated management strategies for coexisting conditions like uveitis 1.
  • Key Recommendations

  • Initiate treatment with NSAIDs for symptomatic relief in mild cases (Evidence: Moderate) 1.
  • Introduce methotrexate as first-line DMARD for moderate to severe JIA affecting the foot (Evidence: Strong) 1.
  • Consider TNF inhibitors for patients with inadequate response to conventional DMARDs (Evidence: Moderate) 1.
  • References

    1 Haridas RP. James Young Simpson's . Anaesthesia and intensive care 2025. link

    Original source

    1. [1]
      James Young Simpson's Haridas RP Anaesthesia and intensive care (2025)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG